Levodopa/Carbidopa/Entacapon Beta

Levodopa, Carbidopa, Entacapone, the active ingredients in Levodopa/Carbidopa/Entacapone Beta, are a dopamine precursor with peripheral DOPA decarboxylase inhibition and COMT inhibition presented as an oral tablet for oral use. It treats Parkinson's disease as an adjunct to levodopa therapy in adult patients.

GNH USA supplies Levodopa/Carbidopa/Entacapone Beta as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levodopa/Carbidopa/Entacapone is indicated for Parkinson's disease and related motor complications, acting as an adjunct to levodopa therapy.

- Parkinson's disease: improves overall motor function when added to levodopa. - Motor fluctuations in Parkinson's disease: reduces OFF time and stabilises response. - Early-stage Parkinson's disease: enhances the effectiveness of levodopa and delays progression of symptoms.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: sensation of light‑headedness, especially on standing. - Headache: transient cranial discomfort. - Orthostatic hypotension: drop in blood pressure upon standing. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe dyskinesia: uncontrolled involuntary movements. - Neuroleptic malignant syndrome: life‑threatening hyperthermia and rigidity. - Cardiac arrhythmias: irregular heart rhythms. - Hallucinations or psychosis: visual or auditory disturbances. - Severe hypotension: marked blood pressure decline requiring medical attention. - Hyperthermia: unexplained high body temperature.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor blood pressure: check for orthostatic changes and treat hypotension. - Assess for dyskinesia: observe for involuntary movements during treatment. - Review hepatic function: use caution in patients with liver disease. - Avoid in narrow‑angle glaucoma: risk of increased intra‑ocular pressure. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Levodopa/Carbidopa/Entacapone can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: may precipitate hypertensive crisis. - Anticholinergic agents: can mask Parkinsonian symptoms. - CNS depressants: increase sedation and dizziness.

Moderate Interactions (Monitor Closely): - Antihypertensive drugs: additive blood‑pressure‑lowering effect. - SSRIs or SNRIs: potential for serotonin syndrome. - Iron or calcium supplements: reduce levodopa absorption; separate dosing times.